Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, HEC30654, in Healthy Chinese Subjects.

Li, Xiaojiao; Gao, Lei; Liu, Jingrui; Zhang, Hong; Chen, Hong; Yang, Lizi; Wu, Min; Li, Cuiyun; Zhu, Xiaoxue; Ding, Yanhua; Sun, Li

Li, Xiaojiao; Gao, Lei; Liu, Jingrui; Zhang, Hong; Chen, Hong; Yang, Lizi; Wu, Min; Li, Cuiyun; Zhu, Xiaoxue; Ding, Yanhua; Sun, Li.

Affiliation

Li X; Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, China.
Gao L; Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, China.
Liu J; Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, China.
Zhang H; Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, China.
Chen H; Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, China.
Yang L; Nanguan District Maternal and Child Health and Family Planning Service Center of Changchun, Changchun, China.
Wu M; Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, China.
Li C; Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, China.
Zhu X; Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, China.
Ding Y; Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, China.
Sun L; Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, China.

Front Pharmacol ; 12: 726536, 2021.

Article in En | MEDLINE | ID: mdl-34489712

Key words

5-HT6 receptor antagonist; HEC30654; pharmacokinetics; phase I; safety

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Guideline / Prognostic_studies Language: En Journal: Front Pharmacol Year: 2021 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google